-
1Academic Journal
Συγγραφείς: Y. V. Zhitkova, A. A. Gasparian, A. F. Sarvarova, D. A. Korobova, F. I. Galyavova, A. I. Baynazarova, A. M. Khamidullina, E. V. Domanskaya, Ю. В. Житкова, Г. А. Гаспарян, А. Ф. Сарварова, Д. А. Коробова, Ф. И. Галявова, А. И. Байназарова, А. М. Хамидуллина, Е. В. Доманская
Πηγή: Meditsinskiy sovet = Medical Council; № 3 (2024); 43-50 ; Медицинский Совет; № 3 (2024); 43-50 ; 2658-5790 ; 2079-701X
Θεματικοί όροι: поддержание самообслуживания пациента с деменцией, cognitive impairment, Alzheimer’s disease, cognitive stimulation therapy, non-drug treatments for dementia, cognitive training, supporting self-care of a patient with dementia, деменция, болезнь Альцгеймера, когнитивная стимулирующая терапия, нелекарственные методы лечения деменции, когнитивный тренинг
Περιγραφή αρχείου: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/8182/7210; Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113): 2673–734. https://doi.org/10.1016/S0140-6736(17)31363-6.; Парфенов ВА, Захаров ВВ, Преображенская ИС. Когнитивные расстройства. М.; 2014. 192 с.; Парфенов ВА. Болезнь Альцгеймера: ошибки ведения пациентов. Медицинский совет. 2020;(19):23–28. https://doi.org/10.21518/2079-701X-2020-19-23-28.; Локшина АБ, Гришина ДА. Терапия некогнитивных нервно-психических расстройств при болезни Альцгеймера. Неврология, нейропсихиатрия, психосоматика. 2021;13(6):132–138. https://doi.org/10.14412/2074-2711-2021-6-132-138.; Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017;389(10076):1323–1335. https://doi.org/10.1016/S0140-6736(16)3238.; Михайлова НМ. Деменции позднего возраста: смертность и сроки дожития. Психиатрия. 2019;17(2):54–67. https://doi.org/10.30629/2618-6667-2019-17-2-54-67.; Helmer C, Joly P, Letenneur L, Commenges D, Dartigues JF. Mortality with Dementia: Results from a French Prospective Community-based Cohort. Am J Epidemiol. 2001;154(7):642–648. https://doi.org/10.1093/aje/154.7.642.; Rait G, Walters K, Bottomley C, Petersen I, Iliffe S, Nazareth I. Survival of people with clinical diagnosis of dementia in primary care: cohort study. BMJ. 2010;341:c3584. https://doi.org/10.1136/bmj.c3584.; Villarejo A, Benito-León J, Trincado R, Posada IJ, Puertas-Martín V, Boix R et al. Dementia-associated mortality at thirteen years in the NEDICES Cohort Study. J Alzheimers Dis. 2011;26(3):543–551. https://doi.org/10.3233/JAD-2011-110443.; Gillum RF, Yorrick R, Obisesan ThO. Population Surveillance of Dementia Mortality Int. J Environ Res Public Health. 2011;8(4):1244–1257. https://doi.org/10.3390/ijerph8041244.; Хасанова ДР, Житкова ЮВ, Яушева ЛМ. Лекарственная терапия и когнитивное стимулирование у больных с постинсультными когнитивными нарушениями. Неврология, нейропсихиатрия, психосоматика. 2014;(2S):22–27. https://doi.org/10.14412/2074-2711-2014-2S-22-27.; Spector A, Orrell M, Davies S, Woods B. Can reality orientation be rehabilitated? Development and piloting of an evidence based programme of cognition-based therapies for people with dementia. Neuropsychol Rehabil. 2001;11(3–4):377–397. https://doi.org/10.1080/09602010143000068.; Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, Orrell M. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: Randomised Controlled Trial. Br J Psychiatry. 2003;183:248–254. https://doi.org/10.1192/bjp.183.3.248.; Spector A, Gardner C, Orrell M. The impact of Cognitive Stimulation Therapy groups on people with dementia: views from participants, their carers and group facilitators. Aging Ment Health. 2011;15(8):945–949. https://doi.org/10.1080/13607863.2011.586622.; Orrell M, Spector A, Thorgrimsen L, Woods B. A pilot study examining the effectiveness of maintenance Cognitive Stimulation Therapy (MCST) for people with dementia. Int J Geriatr Psychiatry. 2005;20(5):446–451. https://doi.org/10.1002/gps.1304.; Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, Orrell M. Cognitive Stimulation Therapy for people with dementia: cost effectiveness analysis. Br J Psychiatry. 2006;188:574–580. https://doi.org/10.1192/bjp.bp.105.010561.; Aguirre E, Hoare Z, Streater A, Spector A, Woods B, Hoe J, Orrell M. Cognitive stimulation therapy (CST) for people with dementia – who benefits most? Int J Geriatr Psychiatry. 2013;28(3):284–290. https://doi.org/10.1002/gps.3823.; Lobbia A, Carbone E, Faggian S, Gardini S, Piras F, Spector A, Borella E. The efficacy of cognitive stimulation therapy (CST) for people with mild-to-moderate dementia. Eur Psychol. 2018;24(3). https://doi.org/10.1027/1016-9040/a000342.; Niu YX, Tan JP, Guan JQ, Zhang ZQ, Wang LN. Cognitive stimulation therapy in the treatment of neuropsychiatric symptoms in Alzheimer’s disease: a randomized controlled trial. Clin Rehabil. 2010;24(12):1102–1111. https://doi.org/10.1177/0269215510376004.; Apóstolo JLA, Cardoso DFB, Rosa AI, Paúl C. The effect of cognitive stimulation on nursing home elders: A randomized controlled trial. J Nurs Scholarsh. 2014;46(3):157–166. https://doi.org/10.1111/jnu.12072.; Orgeta V, Leung P, Yates L, Kang S, Hoare Z, Henderson C et al. Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial. Health Technol Assess. 2015;19(64):1–108. https://doi.org/10.3310/hta19640.; Stott J, Spector A. A review of the effectiveness of memory interventions in mild cognitive impairment (MCI). Int Psychogeriatr. 2011;23(4):526–538. https://doi.org/10.1017/S1041610210001973.; Bahar-Fuchs A, Clare L, Woods B. Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia (Review). Alzheimers Res Ther. 2013;5(4):35. https://doi.org/10.1186/alzrt189.; Piras F, Carbone E, Faggian S, Salvalaio E, Gardini S, Borella E. Efficacy of cognitive stimulation therapy for older adults with vascular dementia. Dement Neuropsychol. 2017;11(4):434–441. https://doi.org/10.1590/1980-57642016dn11-040014.; Clare L, Woods RT. Cognitive training and cognitive rehabilitation for people with early-stage Alzheimer’s disease: A review. Neuropsychol Rehabil. 2004;14(4):385–401. https://doi.org/10.1080/09602010443000074.; Gibbor L, Yates L, Volkmer A, Spector A. Cognitive stimulation therapy (CST) for dementia: a systematic review of qualitative research. Aging Mental Health. 2021;25(6):980–990. https://doi.org/10.1080/13607863.2020.1746741.; Cao Y, Wang N, Zhang Q, Shen N, Bai J, Luo X, Liu Y. Effects of cognitive stimulation therapy on patients with dementia: An umbrella review of systematic reviews and meta-analyses. Exp Gerontol. 2023;177:112197. https://doi.org/10.1016/j.exger.2023.112197.; Aguirre E, Spector A, Hoe J, Russell IT, Knapp M, Woods RT, Orrell M. Maintenance Cognitive Stimulation Therapy (CST) for dementia: a single-blind, multi-centre, randomized controlled trial of Maintenance CST vs. CST for dementia. Trials. 2010;11:46. https://doi.org/10.1186/1745-6215-11-46.; Fairbairn А, Gould N, Kendall Т, Ashley Р, Bainbridge I, Bower L et al. Dementia: A NICE-SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care. Leicester (UK): British Psychological Society; 2007.; Рощина ИФ, Калантарова МВ, Шведовская АА, Хромов АИ. Профилактика когнитивного снижения в позднем онтогенезе: программы «Клиника памяти» и «Когнитивная стимулирующая терапия». Клиническая и специальная психология. 2022;11(3):44–70. https://doi.org/10.17759/cpse.2022110302.
-
2Academic Journal
Συγγραφείς: A. A. Naumenko, I. S. Preobrazhenskaya, А. А. Науменко, И. С. Преображенская
Συνεισφορές: Мерц Фарма, ООО
Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 10, No 4 (2018); 81-87 ; Неврология, нейропсихиатрия, психосоматика; Vol 10, No 4 (2018); 81-87 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2018-4
Θεματικοί όροι: когнитивно-моторный тренинг, vascular cognitive impairment, dementia, moderate cognitive impairment, pathogenetic therapy, basic symptomatic therapy, NMDA receptor antagonists, acatinol, acetylcholinesterase inhibitors, non-drug treatments, cognitive and motor training, сосудистые когнитивные нарушения, деменция, умеренные когнитивные нарушения, патогенетическая терапия, базисная симптоматическая терапия, антагонисты NMDA-рецепторов, акатинол, ингибиторы ацетилхолинэстеразы, нелекарственные методы лечения
Περιγραφή αρχείου: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/1001/816; Petersen RC, Stevens JC, Ganguli M, et al. Mild cognitive impairment (an evidence-based review). Neurology. 2001 May 8;56(9):1133-42.; Petersen RC. Mild cognitive impairment as a diagnostic entity. JIntern Med. 2004 Sep;256(3): 183-94.; Парфенов ВА, Захаров ВВ, Преображенская ИС. Когнитивные расстройства. Москва: Ремедиум; 2014. 106 с.; Парфенов ВА, Неверовский ДВ. Ведение пациентов с дисциркуляторной энцефалопатией в амбулаторной практике. Неврология, нейропсихиатрия, психосоматика. 2015; 7(1):37-42. doi:10.14412/2074-2711-2015-1-37-42; Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002 Oct-Dec;16(4):203-12.; Kivipelto M, Helkala EL, Laakso M, et al. Middle life vascular risk factors and Alzheimer’s disease in later life: longitudinal population based study. BMJ. 2001 Jun 16;322(7300):1447-51.; Skoog I, Gustafson D. Clinical trials for primary prevention in dementia. In: Rockwood K, Gauthier S, editors. Dementia therapeutic research. London a New York: Taylor a Francis; 2006. P. 189-212.; Iqbal K, Winblad B, Nishumura T, et al, editors. Alzheimer's disease: biology, diagnosis and therapeutics. J. Willey and sons; 1997. 831 p.; Преображенская ИС. Постинсультные когнитивные расстройства: причины, клинические проявления, лечение. Фарматека. 2013;(9):49-53. [Preobrazhenskaya IS. Poststroke cognitive disorders: causes, clinical manifestations, treatment. Farmateka. 2013;(9):49-53. (In Russ.)].; Barba R, Castro MD, del Mar Morin M, et al. Prestroke dementia. Cerebrovasc Dis. 2001;11(3):216-24.; Hachinski V. Vascular dementia: radical redefinition. In: Carlson LA, Gottfries SG; Winblad B, editors. Vascular dementia: etiology, pathogenesis and clinical aspects. S. Karger; 1994. P. 2-4.; Kawashima R. Mental Exercises for Cognitive Function: Clinical Evidence. J Prev Med Public Health. 2013 Jan;46 Suppl 1:S22-7. doi:10.3961/jpmph.2013.46.S.S22. Epub 2013 Jan 30.; Li X, Li D, Li Q, et al. Hippocampal subfield volumetry in patients with subcortical vascular mild cognitive impairment. Sci Rep. 2016 Feb 15;6:20873. doi:10.1038/srep20873.; O’Brien J, Ames D, Gustafson L, et al, editors. Cerebrovascular disease, cognitive impairment and dementia. Second edition. Martin Dunitz; 2004.; Gorelick PB, Scuteri A, Black SE, et al. Vascular Contributions to cognitive impairment and dementia: A Statement for healthcare Professionals from the American Heart Association / American Stroke Association. Stroke. 2011 Sep;42(9):2672-713. doi:10.1161/ STR.0b013e3182299496. Epub 2011 Jul 21.; Парфенов ВА. Профилактика болезни Альцгеймера. Неврология, нейропсихиатрия, психосоматика. 2011;3(3):8-13.; Fu C, Chute DJ, Farag ES, et al. Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med. 2004 Jan;128(1):32-8.; Hulette CM. Brain banking in the United States. JNeuropathol Exp Neurol. 2003 Jul; 62(7):715-22.; Knopman DS, Parisi JE, Boeve BF, et al. Vascular dementia in a population-based autopsy study. Arch Neurol. 2003 Apr;60(4):569-75.; Baskys A, Hou AC. Vascular dementia: pharmacological treatment approaches and perspectives. Clin Interv Aging. 2007;2(3):327-35.; Kim GH, Lee JH, Seo SW, et al. Hippocampal volume and shape in pure subcortical vascular dementia. Neurobiol Aging. 2015 Jan;36(1):485-91. doi:10.1016/j.neurobiolag-ing.2014.08.009. Epub 2014 Sep 28.; Захаров ВВ. Медикаментозная терапия в восстановительном периоде инсульта. Фар-матека. 2015;(9):80-7.; Butefisch CM. Plasticity in the human cerebral cortex: lessons from the normal brain and from stroke. Neuroscientist. 2004 Apr;10(2):163-73.; L0mo T. The discovery of long-term potentiation. Philos Trans R Soc Lond B Biol Sci. 2003 Apr 29;358(1432):617-20.; Ziemann U, Muellbacher W, Hallett M, Cohen LG. Modulation of practice-dependent plasticity in human motor cortex. Brain. 2001 Jun;124(Pt 6):1171-81.; Захаров ВВ. Глутаматергическая терапия в восстановительном периоде после ишемического инсульта. Эффективная фармакотерапия. Неврология. 2014;(4):6-16.; Thomas SJ, Grossberg GT. Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias. Clin Interv Aging. 2009;4:367-77. Epub 2009 Oct 12.; Areosa Sastre A, Sheriff F, McShane R. Memantine for dementia. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003154.; Orgogozo JM, Rigaud AS, Sto ffler A, et al. Efficacy and Safety of Memantine in Patients with Mild to Moderate Vascular Dementia a Randomized, Placebo-Controlled Trial (MMM 300). Stroke. 2002 Jul;33(7):1834-9.; Wilcock G, Mo bius HJ, Sto ffler A; MMM 500 group. A double-blind, placebo-controlled multicenter study of Memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol. 2002 Nov;17(6):297-305.; Левин ОС, Юнищенко НА, Дударова МА. Эффективность акатинола мемантина при умеренно выраженном когнитивном расстройстве. Журнал неврологии и психиатрии им. С.С. Корсакова. 2009;(7):36-42.; Яхно НН, Преображенская ИС, Захаров ВВ, Мхитарян ЭА. Эффективность мемантина у пациентов с недементными когнитивными расстройствами. Результаты многоцентрового клинического наблюдения. Неврологический журнал. 2010;15(2): 52-8.; Woods B, Aguirre E, Spector AE, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD005562. doi:10.1002/14651858.CD005562.pub2.; Martin M, Clare L, Altgassen AM, et al. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev. 2011 Jan 19; (1):CD006220. doi:10.1002/14651858.CD006220.pub2.; Young J, Angevaren M, Rusted J, Tabet N. Aerobic exercise to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev. 2015 Apr 22;(4):CD005381. doi:10.1002/14651858.CD005381.pub4.; Rodakowski J, Saghafi E, Butters MA, Skidmore ER. Non-pharmacological interventions for adults with mild cognitive impairment and early stage dementia: An updated scoping review. Mol Aspects Med. 2015 Jun-Oct; 43-44:38-53. doi:10.1016/j.mam.2015.06.003. Epub 2015 Jun 10.; Науменко АА, Громова ДО, Преображенская ИС. Когнитивный тренинг и реабилитация пациентов с когнитивными нарушениями. Доктор. Ру. 2017;(11):31-8.; Baker LD, Frank LL, Foster-Schubert K, et al. Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial. Arch Neurol. 2010 Jan;67(1):71-9. doi:10.1001/arch-neurol.2009.307.; Schmidt W, Endres M, Dimeo F, Jungehulsing GJ. Train the vessel, gain the brain: physical activity and vessel function and the impact on stroke prevention and outcome in cerebrovascular disease. Cerebrovasc Dis. 2013; 35(4):303-12. doi:10.1159/000347061. Epub 2013 Apr 10.; Bherer L. Cognitive plasticity in older adults: effects of cognitive training and physical exercise. Ann N YAcad Sci. 2015 Mar;1337:1-6. doi:10.1111/nyas.12682.; Bherer L, Kramer AF, Peterson MS, et al. Transfer effects in task-set cost and dual-task cost after dual-task training in older and younger adults: further evidence for cognitive plasticity in attentional control in late adulthood. Exp Aging Res. 2008 Jul-Sep;34(3): 188-219. doi:10.1080/03610730802070068.; Kolb B, Gibb R. Principles of neuroplasticity and behavior. In: Stuss D, Winocur G, Robertson I, editors. Cognitive neurorehabilitation: Evidence and Application. New York: Cambridge University Press; 2008. P. 6-21.; Wilson RS, Scherr PA, Schneider JA, et al. Relation of cognitive activity to risk of developing Alzheimer disease. Neurology. 2007 Nov 13; 69(20):1911-20. Epub 2007 Jun 27.; Wada M, Noda Y, Shinagawa S, et al. Effect of Education on Alzheimer’s Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer’s Disease: A CrossSectional Study. JAlzheimers Dis. 2018;63(2): 861-869. doi:10.3233/JAD-171168.; Bayer-Carter JL, Green PS, Montine TJ, et al. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol. 2011 Jun;68(6):743-52. doi:10.1001/archneurol.2011.125.; Del Parigi A, Panza F, Capurso C, Solfrizzi V. Nutritional factors, cognitive decline, and dementia. Arch Neurol. 2011 Jun; 68(6):743-52. doi:10.1001/archneurol.2011.125.; Morris MC, Evans DA, Tangney CC, et al. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology. 2006 Oct 24;67(8):1370-6.; Rozzini L, Costardi D, Chilovi BV, et al. Efficacy of Cognitive Rehabilitation in Patients with Mild Cognitive Impairment Treated with Cholinesterase Inhibitors. John Wiley & Sons; 2007. P. 356-60.
-
3Academic Journal
Συγγραφείς: Aleksei Vladimirovich Sergeev
Πηγή: Neurology, Neuropsychiatry, Psychosomatics; Vol 5, No 3 (2013); 78-85 ; Неврология, нейропсихиатрия, психосоматика; Vol 5, No 3 (2013); 78-85 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2013-3
Θεματικοί όροι: доказательная медицина, nonsteroidal anti-inflammatory drugs, pharmacotherapy, nondrug treatment, evidence-based medicine, нестероидные противовоспалительные препараты, фармакотерапия, нелекарственные методы лечения
Περιγραφή αρχείου: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/259/227; Airaksinen O, Brox JI, Cedraschi C et al. Chapter 4. European guidelines for the management of chronic nonspecifi c low backpain. Eur Spine J. 2006;15 suppl 2:S192–300. Walker BF. The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. Journal of Spinal Disorders. 2000;13(3):205–17. DOI:10.1097%2F00002517-200006000-00003. Подчуфарова ЕВ. Яхно НН. Боль в спине. Москва: ГЕОТАР Медиа; 2010. 368 c. [Podchufarova EV. Yakhno NN. Bol' v spine. Moscow: GEOTAR Media; 2010. 368 p.] Waddell G. The clinical course of low back pain. In: The back pain revolution. Edinburgh: Churchill Livingstone. 1998. Р. 103–17. Government Accountability Office. Medicare Part B imagingservices: rapid spending growth and shift to physician officesindicate need for CMA to consider additional managementpractices. Washington, DC: Government Accountability Office; 2008. Andersson GB. Low back pain. J Rehabil Res Dev. 1997;34:9–10. Loney PL, Stratford PW. The prevalence of low back pain in adults: a methodological review of theliterature. Phys Ther. 1999;79(4):384–96. Павленко СС. Эпидемиология боли. Неврологический журнал. 1999;4(1):41–6. [Pavlenko SS. Epidemiologiya boli. Nevrologicheskiy zhurnal. 1999;4(1):41–6.] Боль: руководство для врачей и студентов. Под ред. акад. Яхно НН. Москва: МЕДпресс-информ; 2009. 304 с. [Bol': rukovodstvo dlya vrachey i studentov. Pod red. akad. Yakhno NN. Moscow: MEDpress-inform; 2009. 304 p.] Матросов ДН, Галушко ЕА, Эрдес ШФ. Эпидемиология болей в нижней части спины в амбулаторной практике. Боль. 2009;4(25):23–8. [Matrosov DN, Galushko EA, Erdes ShF. Epidemiologiya boley v nizhney chasti spiny v ambulatornoy praktike. Bol'. 2009;4(25):23–8.] Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low backpain? JAMA. 1992;268(6):760–5. Anderson R. A case study in integrative medicine: alternative theories and the language of biomedicine. J Altern Complement Med. 1999;5(2):165–73; discussion 175-6. DOI:10.1089%2Facm.1999.5.165. Natvig B, Bruusgaard D, Eriksen W. Localized low back pain and low back pain as part of widespreadmusculoskeletal pain: two different disorders? A cross-sectionalpopulation study. J Rehabil Med. 2001;33(1):21–5. Van Tulder MW. Low back pain. Best Practice and Research. Clinical Rheumatology. 2002;16:761–75. Endean A, Palmer KT, Coggon D. Potential of magnetic resonanceimaging findings to refine case definition for mechanical low backpain in epidemiological tudies: a systematic review. Spine (Phila Pa 1976). 2011;36(2):160–69. DOI:10.1097/BRS.0b013e3181cd9adb. Balague F, Mannion AF, Pellise F, Cedraschi C. Non-specific low back pain. Lancet. 2012 Feb 4;379(9814):482–91. DOI:10.1016/S0140-6736(11)60610-7. Epub 2011 Oct 6. Heneweer H, Vanhees L, Picavet HS. Physical activity and low backpain: a U-shaped relation? Pain. 2009;143(1–2):21–5. DOI:10.1016/j.pain.2008.12.033. Epub 2009 Feb 12. Shiri R, Karppinen J, Leino-Arjas P et al. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol. 2010;171(2):135–54. DOI:10.1093/aje/kwp356. Epub 2009 Dec 11. Verbunt JA, Smeets RJ, Wittink HM. Cause or effect? Deconditioning and chronic low back pain. Pain. 2010;149(3):428–30. DOI:10.1016/j.pain.2010.01.020. Epub 2010 Feb 12. Kalichman L, Hunter DJ. The genetics of intervertebral discdegeneration. Familial predisposition and heritability estimation. Joint Bone Spine. 2008;75(4):383–87. DOI:10.1016/j.jbspin.2007.11.003. Epub 2008 Apr 29. Karppinen J, Solovieva S, Luoma K et al. Modic changes and interleukin 1 gene locuspolymorphisms in occupational cohort of middle-aged men. Eur Spine J. 2009;18(12):1963–70. DOI:10.1007/s00586-009-1139-x. Epub 2009 Aug 22. Kent P, Keating J. Do primary-care clinicians think that nonspecificlow back pain is one condition? Spine (Phila Pa 1976). 2004;29(9):1022–31. Kamper SJ, Maher CG, Hancock MJ et al. Treatment-basedsubgroups of low back pain: a guide to appraisalof research studies and a summary of current evidence. Best Pract Res Clin Rheumatol. 2010; 24(2):181–91. DOI:10.1016/j.berh.2009.11.003. Dionne CE, Dunn KM, Croft PR, et al. A consensus approachtoward the standardization of back pain definitions for use inprevalence studies. Spine (Phila Pa 1976). 2008;33(1):95–103. DOI:10.1097/BRS.0b013e31815e7f94. Chou R, Shekelle P. Will this patient develop persistent disablinglow back pain? JAMA. 2010;303(13):1295–302. DOI:10.1001/jama.2010.344. Burton AK, Balague F, Cardon G et al. Chapter 2. Europeanguidelines for prevention in low back pain: November 2004. Eur Spine J. 2006;15 suppl 2:S136–68. Dahm KT, Brurberg KG, Jamtvedt G, Hagen KB. Advice to rest in bed versus advice to stay active for acute low-back pain and sciatica. Cochrane Database Syst Rev. 2010;(6):CD007612. DOI:10.1002/14651858.CD007612.pub2. Vroomen PC, de Krom MC, Wilmink JT et al. Lack of effectiveness of bed rest for sciatica. N Engl J Med. 1999;340(6):418. DOI:10.1056%2FNEJM199902113400602. Krismer M, van Tulder M; Low Back Pain Group of the Bone and Joint Health Strategies for Europe Project. Strategies for prevention and management of musculoskeletal conditions. Low back pain (non-specific). Best Pract Res Clin Rheumatol. 2007 Feb;21(1):77–91. Linton SJ, van Tulder MW. Preventive interventions for back and neck pain problems: what is the evidence? Spine (Phila Pa 1976). 2001;26(7):778–87. DOI:10.1097%2F00007632-200104010-00019. Choi BK, Verbeek JH, Tam WW, Jiang JY. Exercises for prevention of recurrences of low-back pain. Cochrane Database Syst Rev 2010;(1): CD006555. DOI:10.1002/14651858.CD006555.pub2. Review. Roelofs PD, Deyo RA, Koes BW et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008;(1): CD000396. DOI:10.1002/14651858.CD000396.pub3. Review. Chou R, Qaseem A, Snow V et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478–91. DOI:10.7326%2F0003-4819-147-7-200710020-00006. Алексеев ВВ. Ступенчатая терапия НПВП острого болевого синдрома в пояснично-крестцовой области. Эффективная фармакотерапия в неврологии и психиатрии. 2010;4:22–8. [Alekseev VV. Stupenchataya terapiya NPVP ostrogo bolevogo sindroma v poyasnichno-kresttsovoy oblasti. Effektivnaya farmakoterapiya v nevrologii i psikhiatrii. 2010;4:22–8.] Алексеев ВВ. Диагностика и лечение острых поясничных болей. Consilium Medicum. 2009;11(2):42–6. [Alekseev VV. Diagnostika i lechenie ostrykh poyasnichnykh boley. Consilium Medicum. 2009;11(2):42–6.] Эрдес ШФ. Неспецифическая боль в нижней части спины. Клинические рекомендации для участковых терапевтов и врачей общей практики. Москва: КомплектСервис; 2008. 70 c. [Erdes ShF. Nespetsificheskaya bol' v nizhney chasti spiny. Klinicheskie rekomendatsii dlya uchastkovykh terapevtov i vrachey obshchey praktiki. Moskva: KomplektServis; 2008. 70 p.] Каратеев АЕ, Яхно НН, Лазебник ЛБ и др. Применение нестероидных противовоспалительных препаратов. (Клинические рекомендации). Москва: ИМА–ПРЕСС; 2009. 168 с. [Karateev AE, Yakhno NN, Lazebnik LB i dr. Primenenie nesteroidnykh protivovospalitel'nykh preparatov. (Klinicheskie rekomendatsii). Moscow: IMA–PRESS; 2009. 168 p.] Forrest JB. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth. 2002;88(2):227–33. Veenema KR, Leahey N, Schneider S. Ketorolac versus meperidine: ED treatment of severe musculoskeletal low back pain. Am J Emerg Med. 2000;18(4):404–7. DOI:10.1053%2Fajem.2000.7314. Jelinek GA. Ketorolac versus morphine for severe pain. Ketorolac is more effective, cheaper, and has fewer side effects. BMJ. 2000;321(7271):1236–7. Верткин АЛ, Тополянский АВ, Вовк ЕЙ. Место кеторолака в терапии острых болевых синдромов на догоспитальном этапе. Consilium Medicum. 2006;8(2):86–90. [Vertkin AL, Topolyanskiy AV, Vovk EY. Mesto ketorolaka v terapii ostrykh bolevykh sindromov na dogospital'nom etape. Consilium Medicum. 2006;8(2):86–90.] Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286(8):954–9. DOI:10.1001%2Fjama.286.8.954. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006;296(13):1633–44. DOI:10.1001%2Fjama.296.13.jrv60011. Epub 2006 Sep 12. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to the use of non-steroidal antiinflammatory drugs: meta-analysis. Ann Intern Med. 1991;115(10):787–96. Borhade N, Pathan AR, Halder S et al. NO-NSAIDs. Part 3: nitric oxide-releasing prodrugs of non-steroidal anti-inflammatory drugs. Chem Pharm Bull (Tokyo). 2012;60(4):465–81. DOI:10.1248%2Fcpb.60.465. Marcolongo R, Frediani B, BiasiG et al. A meta-analysis of the tolerability of amtolmetin guacil, a novel, effective nonsteroidal anti-inflammatory drug, compared with established agents. Clin Drug Invest. 1999 Feb;17(2):89–96. Riezzo G, Chiloiro M, Montanaro S. Protective effects of amtometinguacylverus placebo diclofenac and mioprostol in healthy volunteers evaluated as gastric electrical activity in alcohol-induced stomach damage. Dig Dis Sci. 2001;46(8):1797–1804. Li YH, Li J, Huang Y et al. Gastroprotective effect and mechanism of amtolmetinguacyl in mice. World J Gastroenterol. 2004;10(24):3616–20. Van Tulder MW, Touray T, Furlan AD et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev. 2003;(2):CD004252. DOI:10.1002%2F14651858.CD004252. Beebe FA, Barkin RL, Barkin S. A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. Am J Ther. 2005;12(2):151–71. Berry H, Hutchinson DR. Tizanidine and ibuprofen in acute low–back pain: Results of a double–blind multicentre study in general practice. J Int Med Res. 1988;16(2):83–91. Парфенов ВА. Причины, диагностика и лечение боли в нижней части спины. Неврология, нейропсихиатрия, психосоматика. 2010;(1):19–22. [Parfenov VA. Low back pain: causes, diagnosis and treatment. Nevrologiya, neyropsikhiatriya, psikhosomatika. 2010;(1):19–22.] Martell BA, O’Connor PG, Kerns RD et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–27. DOI:10.7326%2F0003-4819-146-2-200701160-00006. Friedman BW, Holden L, Esses D et al. Parenteral corticosteroids for Emergency Department patients with non-radicular low back pain. J Emerg Med. 2006;31(4):365–70. Walker BF, French SD, Grant W, Green S. Combined chiropractic interventions for low-back pain. Cochrane Database Syst Rev. 2010;(4):CD005427. DOI:10.1002/14651858.CD005427.pub2. Kalauokalani D, Cherkin DC, Sherman KJ et al. Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine (Phila Pa 1976). 2001;26(13):1418–24. DOI:10.1097%2F00007632-200107010-00005. Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology. 2001;56(10):1290–3. DOI:10.1212%2FWNL.56.10.1290.
-
4Academic Journal
Συγγραφείς: Сергеев, Алексей
Θεματικοί όροι: БОЛЬ В НИЖНЕЙ ЧАСТИ СПИНЫ, НЕСТЕРОИДНЫЕ ПРОТИВОВОСПАЛИТЕЛЬНЫЕ ПРЕПАРАТЫ, ФАРМАКОТЕРАПИЯ, НЕЛЕКАРСТВЕННЫЕ МЕТОДЫ ЛЕЧЕНИЯ, ДОКАЗАТЕЛЬНАЯ МЕДИЦИНА
Περιγραφή αρχείου: text/html
-
5Academic Journal
Συγγραφείς: Наприенко, М., Михайлова, А., Гресс, А., Гань, Дзюнда
Θεματικοί όροι: ГОЛОВНЫЕ БОЛИ, ЦЕФАЛГИИ, НЕЛЕКАРСТВЕННЫЕ МЕТОДЫ ЛЕЧЕНИЯ, РЕФЛЕКСОТЕРАПИЯ
Περιγραφή αρχείου: text/html
-
6Academic Journal
Πηγή: Неврология, нейропсихиатрия, психосоматика.
Θεματικοί όροι: БОЛЬ В НИЖНЕЙ ЧАСТИ СПИНЫ, НЕСТЕРОИДНЫЕ ПРОТИВОВОСПАЛИТЕЛЬНЫЕ ПРЕПАРАТЫ, ФАРМАКОТЕРАПИЯ, НЕЛЕКАРСТВЕННЫЕ МЕТОДЫ ЛЕЧЕНИЯ, ДОКАЗАТЕЛЬНАЯ МЕДИЦИНА, 3. Good health
Περιγραφή αρχείου: text/html
-
7Academic Journal
Πηγή: Вестник новых медицинских технологий.
Θεματικοί όροι: ГОЛОВНЫЕ БОЛИ, ЦЕФАЛГИИ, НЕЛЕКАРСТВЕННЫЕ МЕТОДЫ ЛЕЧЕНИЯ, РЕФЛЕКСОТЕРАПИЯ, 3. Good health
Περιγραφή αρχείου: text/html
